V A Alabaster - Concepedia

Author

V A Alabaster

Also Known As

V A Alabaster, V. A. ALABASTER, V. A. Alabaster, V. Alabaster, V.A. Alabaster, VALERIE A. ALABASTER, Valerie A. Alabaster

Publications

983

Citations

H-Index

Concepts

All Affiliations

Pfizer (United Kingdom)Royal College of Surgeons of England The Honourable Society of Lincoln's Inn

About

V A Alabaster is an author at Pfizer (United Kingdom) specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	581
2	Biochemistry	5	5	277
3	Anesthesia	3	3	95
4	Health Sciences	1	1	29
5	Metabolism	1	1	11

V A Alabaster

Publications

838

Citations

H-Index

Page 1

	Year	Citations
Activity of Various Fractions of Bradykinin Potentiating Factor against Angiotensin I Converting Enzyme S. H. Ferreira, Lewis Joel Greene, V A Alabaster, Nature Molecular PharmacologyBiochemistryMedicineVascular PharmacologyPhysiology	1970	191
Removal of 5‐hydroxytryptamine in the pulmonary circulation of rat isolated lungs V A Alabaster, Y.S. Bakhle British Journal of Pharmacology	1970	162
The fall and rise of in vivo pharmacology V A Alabaster Trends in Pharmacological Sciences Molecular PharmacologyPharmacological StudyMedicineLocal PharmacologyExperimental Pharmacology	2002	57
Comparison of potency of α<sub>2</sub>‐adrenoceptor antagonists<i>in vitro</i>: evidence for heterogeneity of α<sub>2</sub>‐adrenoceptors V A Alabaster, Ruth F. Keir, Christopher J. Peters British Journal of Pharmacology	1986	51
Sites of uptake of3H-5-hydroxytryptamine in rat isolated lung Shirley A. M. Cross, V A Alabaster, Y.S. Bakhle, Histochemistry and Cell Biology Respiratory ToxicologyMedicinePhysiologyPulmonary PharmacologyToxicology	1974	41
The inactivation of bradykinin in the pulmonary circulation of isolated lungs V A Alabaster, Y.S. Bakhle British Journal of Pharmacology Acute Lung InjuryLung InflammationPulmonary ArteryPeptide ScienceIsolated Lungs	1972	36
The removal of noradrenaline in the pulmonary circulation of rat isolated lungs V A Alabaster, Y.S. Bakhle British Journal of Pharmacology Constant RemovalPulmonary ArteryPharmacotherapyIsolated LungsExperimental Pharmacology	1973	36
Comparison of activity of alpha-adrenoceptor agonists and antagonists in dog and rabbit saphenous vein V A Alabaster, Ruth F. Keir, Christopher J. Peters Naunyn-Schmiedeberg s Archives of Pharmacology Animal PhysiologyAdrenal GlandRabbit Saphenous VeinAlpha-adrenoceptor AgonistsMedicine	1985	36
Discovery and Development of Selective M3 Antagonists for Clinical Use V A Alabaster The Journal of Urology PharmacotherapyExperimental PharmacologyTranslational PharmacologyPre-clinical PharmacologyDrug Resistance	1998	29
A study of the muscarinic receptor subtype mediating mucus secretion in the cat trachea in vitro Paul R. Gater, V A Alabaster, Ian T. Piper Pulmonary Pharmacology TracheobronchitisSignal TransductionMolecular PhysiologyMuscarinic Receptor SubtypeMedicine	1989	27

Page 1